\begin{table}[hb!]
\begin{center}
\begin{threeparttable}
\begin{tabular}{@{}rccccc@{}}
\multicolumn{1}{l}{} & {\bf \it DmCa\textsubscript{v}3} & {\bf \it RnCa\textsubscript{v}3.1} & {\bf \it RnCa\textsubscript{v}3.1} & {\bf \it HsCa\textsubscript{v}3.2} & {\bf \it RnCa\textsubscript{v}3.3} \\
\multicolumn{1}{l}{{\bf Activation}} & {\bf \it } & {\bf \it } & {\bf \it } & {\bf \it } & {\bf \it } \\ \midrule \addlinespace
V\textsubscript{50} (mV) & -43.3 $\pm$ 1.6 (11) & -38.9 $\pm$ 1.2 (14) & {\bf -40.0 $\pm$ 0.8\cite{park:2006aa}\tnote{a}} & -36.2 $\pm$ 0.6\cite{park:2006aa}\tnote{a} & -29.1 $\pm$ 1.3\cite{park:2006aa}\tnote{a} \\ \addlinespace
$k$ (mV) & 7.7 $\pm$ 1.3 (11) & 6.4 $\pm$ 0.9 (14) & NA & NA & NA \\ \addlinespace \addlinespace
\multicolumn{1}{l}{{\bf Inactivation}} &  &  &  &  &  \\ \midrule \addlinespace
V\textsubscript{50} (mV) & -58.0 $\pm$ 0.7 (5) & -61.3 $\pm$ 0.7 (15) & -64.9 $\pm$ 0.7\cite{park:2006aa}\tnote{a} & -62.0 $\pm$ 0.9\cite{park:2006aa}\tnote{a} & {\bf -55.6 $\pm$ 0.9\cite{park:2006aa}\tnote{a}} \\ \addlinespace \addlinespace
\multicolumn{1}{l}{{\bf Kinetics (10 mV)}} &  &  &  &  &  \\ \midrule \addlinespace
$\tau$\textsubscript{act} (ms) & 0.73 $\pm$ 0.08 (10) & 0.44 $\pm$ 0.09 (5) & 1.8 $\pm$ 0.1\cite{lee:1999aa}\tnote{b} & {\bf 1.7 $\pm$ 0.2\cite{lee:1999aa}\tnote{b}} & 4.7 $\pm$ 0.3\cite{lee:1999aa}\tnote{b} \\ \addlinespace
$\tau$\textsubscript{inact} (ms) & 18.8 $\pm$ 1.0 & 9.4 $\pm$ 0.5 & {\bf 15 $\pm$ 1\cite{lee:1999aa}\tnote{b}} & 14 $\pm$ 1\cite{lee:1999aa}\tnote{b} & 55 $\pm$ 3\cite{lee:1999aa}\tnote{b} \\ \addlinespace \addlinespace
\multicolumn{1}{l}{{\bf Conductance}} &  &  &  &  &  \\ \midrule \addlinespace
I\textsubscript{Ca}/I\textsubscript{Ba} & 0.7 (6) & 1.6 (3) & 1.5\cite{shcheglovitov:2007aa}\tnote{a} & 0.8\cite{shcheglovitov:2007aa}\tnote{a} & {\bf 0.7\cite{shcheglovitov:2007aa}\tnote{a}} \\ \addlinespace \addlinespace
\multicolumn{1}{l}{{\bf Pharmacology}} &  &  &  &  &  \\ \midrule \addlinespace
\multirow{2}{*}{Ni\textsuperscript{2+} (IC\textsubscript{50} $\mu$M)} & \multirow{2}{*}{5.1 (6-12)} & \multirow{2}{*}{276.5 (5-6)} & 167 $\pm$ 15\cite{lee:1999ab}\tnote{a} & {\bf 5.7 $\pm$ 0.3\cite{lee:1999ab}\tnote{a}} & 87 $\pm$ 7\cite{lee:1999ab}\tnote{a} \\ \addlinespace
 &  &  & 250 $\pm$ 22\cite{lee:1999ab}\tnote{b} & 12 $\pm$ 2\cite{lee:1999ab}\tnote{b} & 216 $\pm$ 9\cite{lee:1999ab}\tnote{b}
\end{tabular}
    \begin{tablenotes}
        \item[a] Recorded in \emph{Xenopus} oocytes
        \item[b] Recorded in HEK293 cells
    \end{tablenotes}
\end{threeparttable}
\end{center}
\caption{{\bf Comparison of the biophysical properties of DmCa\textsubscript{v}3 and mammalian T-type calcium channels} \newline
V\textsubscript{50}, potential of half maximal activation or inactivation.
$k$, slope factor from the Boltzmann equation.
Number of oocytes is in parentheses.
The measurements reported in the first two columns labeled DmCa\textsubscript{v}3 and RnCa\textsubscript{v}3.1 were obtained in this study, while the final three columns were taken from published reports.
Bold-faced entries in the final three columns denote the mammalian T-type channel properties most closely matching the properties of DmCa\textsubscript{v}3.
NA, not available.}
\label{tab:1}
\end{table}